Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REPAIR: Tocilizumab for Bone Erosions in Rheumatoid Arthritis
NCT02765074Phase 4Completed
- Sponsor
- Centre Hospitalier Régional d'Orléans
- Start
- Jun 2016
- Primary completion
- Apr 2025
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 4 trial of tocilizumab in rheumatoid arthritis (RA), sponsored by Centre Hospitalier Régional d'Orléans. Started Jun 2016; status: completed.
02
Drugs
tocilizumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02765074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02765074.